Even in patients with rhinitis who do not have asthma, subclinical changes in the lower airways and inflammatory mediators can be detected. The pathogenic role of paranasal sinus infections in ...
The importance of epithelial cells as inflammatory initiators ... Allergic rhinitis and asthma may have common triggers. The concept of 'one airway disease' has relevant implications for the ...
Frevecitinib is under clinical development by Kinaset Therapeutics and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR ...